NCT02056808 - A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG

SMT C1100

Comparison of safety and pharmacokinetic of different dosages of drug

Trial Locations (4)

Heart of England NHS Foundation Trust - Heart Lands Hospital, Birmingham

Alder Hey Children's NHS Foundation Trust, Liverpool

Great Ormond Street for Children NHS Foundation Trust, London

Central Manchester University Hospitals NHS Foundation Trust- Royal Manchester Children's Hospital, Manchester